Skip to content
PIL Logo

MOVICOL-Half

Last Updated on eMC 06-Apr-2016 View document  | Norgine Limited Contact details

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC.  For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 06-Apr-2016 and displayed until Current

Reasons for adding or updating:

  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - pregnancy, breast feeding and fertility
  • Change to section 3 - how to take/use
  • Change to section 6 - date of revision

Updated on 23-Sep-2014 and displayed until 06-Apr-2016

Reasons for adding or updating:

  • Change to section 3 - how to take/use
  • Change to section 4 - how to report a side effect
  • Improved presentation of PIL

Updated on 20-Aug-2013 and displayed until 23-Sep-2014

Reasons for adding or updating:

  • Change to section 2 - pregnancy, breast feeding and fertility
  • Change to section 6 - date of revision

Updated on 17-Aug-2012 and displayed until 20-Aug-2013

Reasons for adding or updating:

  • Change to side-effects
  • Change to drug interactions

Updated on 11-Mar-2010 and displayed until 17-Aug-2012

Reasons for adding or updating:

  • Change to side-effects

Updated on 19-Jun-2008 and displayed until 11-Mar-2010

Reasons for adding or updating:

  • Change due to user-testing of patient information

Updated on 17-Jan-2005 and displayed until 19-Jun-2008

Reasons for adding or updating:

  • Improved Electronic Presentation

Updated on 13-Jan-2005 and displayed until 17-Jan-2005

Reasons for adding or updating:

  • Improved Electronic Presentation

Updated on 17-Sep-2004 and displayed until 13-Jan-2005

Reasons for adding or updating:

  • Improved Electronic Presentation

Updated on 17-Sep-2004 and displayed until 17-Sep-2004

Reasons for adding or updating:

  • Improved Electronic Presentation

Updated on 14-Sep-2004 and displayed until 17-Sep-2004

Reasons for adding or updating:

  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Company contact details

Norgine Limited

Company image
Address

Norgine House, Widewater Place, Moorhall Road, Harefield, Middlesex, UB9 6NS

Fax

+44 (0)1895 825 865

Medical Information e-mail
Telephone

+44 (0)1895 826 600

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Active ingredients

macrogol 3350, potassium chloride, sodium bicarbonate, sodium chloride

Legal categories

P - Pharmacy

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue